Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756

Watchlist Manager
Shandong Xinhua Pharmaceutical Co Ltd Logo
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Watchlist
Price: 15.29 CNY 0.13% Market Closed
Market Cap: 7.5B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Shandong Xinhua Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 15.29 CNY, Shandong Xinhua Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shandong Xinhua Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
52
vs Industry
72
Median 3Y
1.1
Median 5Y
0.9
Industry
2.4
Forward
0.8
More Details
15.9
P/E
P/E
Price to Earnings
15.9
vs History
46
vs Industry
29
Median 3Y
19.3
Median 5Y
15.6
Industry
20.8
Forward
14.7
More Details
20.3
P/OCF
P/OCF
Price to OCF
20.3
vs History
26
vs Industry
26
Median 3Y
20.1
Median 5Y
17.3
Industry
15.4
More Details
16.1
P/FCFE
P/FCFE
Price to FCFE
16.1
vs History
44
vs Industry
25
Median 3Y
20.1
Median 5Y
15.6
Industry
22.8
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
55
vs Industry
49
Median 3Y
2.2
Median 5Y
1.5
Industry
2
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
53
vs Industry
72
Median 3Y
1.2
Median 5Y
1
Industry
2.5
Forward
0.9
More Details
4.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.1
vs History
41
vs Industry
50
Median 3Y
4.4
Median 5Y
3.9
Industry
4.9
More Details
15.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.1
vs History
52
vs Industry
23
Median 3Y
17.8
Median 5Y
15.5
Industry
12.7
Forward
7.5
More Details
15.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.1
vs History
52
vs Industry
26
Median 3Y
17.8
Median 5Y
15.5
Industry
15.8
Forward
14.4
More Details
22.2
EV/OCF
EV/OCF
Enterprise Value to OCF
22.2
vs History
26
vs Industry
25
Median 3Y
21.6
Median 5Y
18.3
Industry
14
More Details
52.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
52.5
vs History
20
vs Industry
11
Median 3Y
49.4
Median 5Y
26.8
Industry
18.3
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
50
vs Industry
52
Median 3Y
1.4
Median 5Y
1.1
Industry
1.7
More Details

Multiples Across Competitors

Competitors Multiples
Shandong Xinhua Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
7.5B CNY 0.9 15.9 15.1 15.1
US
Eli Lilly and Co
NYSE:LLY
704.7B USD 15.7 66.9 38.8 42.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
381.8B USD 4.3 27.1 12.7 16.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.6 18.9 12.5 14.2
CH
Roche Holding AG
SIX:ROG
210.4B CHF 3.6 18.2 10.3 12.2
UK
AstraZeneca PLC
LSE:AZN
168B GBP 4.1 31.3 126.4 193.1
CH
Novartis AG
SIX:NOVN
186.2B CHF 4.2 18.1 11 14.1
US
Merck & Co Inc
NYSE:MRK
212.5B USD 3.3 12.4 8.4 10
IE
Endo International PLC
LSE:0Y5F
162.4B USD 70 -55.5 259.5 650.8
US
Pfizer Inc
NYSE:PFE
131.9B USD 2.1 16.5 8 11.5
P/E Multiple
Earnings Growth PEG
CN
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Average P/E: 25
15.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
66.9
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
27.1
26%
1
DK
Novo Nordisk A/S
CSE:NOVO B
18.9
19%
1
CH
Roche Holding AG
SIX:ROG
18.2
16%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.3
36%
0.9
CH
Novartis AG
SIX:NOVN
18.1
16%
1.1
US
Merck & Co Inc
NYSE:MRK
12.4
18%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -55.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
16.5
29%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Average EV/EBITDA: 395.4
15.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.8
30%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.7
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.5
15%
0.8
CH
Roche Holding AG
SIX:ROG
10.3
8%
1.3
UK
AstraZeneca PLC
LSE:AZN
126.4
9%
14
CH
Novartis AG
SIX:NOVN
11
5%
2.2
US
Merck & Co Inc
NYSE:MRK
8.4
9%
0.9
IE
E
Endo International PLC
LSE:0Y5F
259.5
N/A N/A
US
Pfizer Inc
NYSE:PFE
8
3%
2.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Average EV/EBIT: 1 698.4
15.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42.8
33%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.7
12%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
16%
0.9
CH
Roche Holding AG
SIX:ROG
12.2
9%
1.4
UK
AstraZeneca PLC
LSE:AZN
193.1
21%
9.2
CH
Novartis AG
SIX:NOVN
14.1
8%
1.8
US
Merck & Co Inc
NYSE:MRK
10
12%
0.8
IE
E
Endo International PLC
LSE:0Y5F
650.8
N/A N/A
US
Pfizer Inc
NYSE:PFE
11.5
10%
1.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 243,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.